TrialEuropean journal of clinical pharmacology2011

The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukast.

Tiina Karonen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.